185 related articles for article (PubMed ID: 12911075)
1. Meloxicam and selective COX-2 inhibitors in the management of pain in the palliative care population.
Smith HS; Baird W
Am J Hosp Palliat Care; 2003; 20(4):297-306. PubMed ID: 12911075
[TBL] [Abstract][Full Text] [Related]
2. The second generation of COX-2 inhibitors: what advantages do the newest offer?
Stichtenoth DO; Frölich JC
Drugs; 2003; 63(1):33-45. PubMed ID: 12487621
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of pharmacological profile of meloxicam as an anti-inflammatory agent, with particular reference to its relative selectivity for cyclooxygenase-2 over cyclooxygenase-1.
Ogino K; Hatanaka K; Kawamura M; Katori M; Harada Y
Pharmacology; 1997 Jul; 55(1):44-53. PubMed ID: 9309800
[TBL] [Abstract][Full Text] [Related]
4. [Therapy with preferential and specific COX-2 inhibitors].
Stichtenoth DO; Frölich JC
Internist (Berl); 2001 Mar; 42(3):421-6. PubMed ID: 11277028
[No Abstract] [Full Text] [Related]
5. The new NSAIDs: cox-2 inhibitors.
Capriotti T
Medsurg Nurs; 2000 Dec; 9(6):313-7. PubMed ID: 11904867
[No Abstract] [Full Text] [Related]
6. Meloxicam in rheumatoid arthritis.
Ahmed M; Khanna D; Furst DE
Expert Opin Drug Metab Toxicol; 2005 Dec; 1(4):739-51. PubMed ID: 16863437
[TBL] [Abstract][Full Text] [Related]
7. The non-steroidal anti-inflammatory drugs protect mouse cochlea against acoustic injury.
Hoshino T; Tabuchi K; Hirose Y; Uemaetomari I; Murashita H; Tobita T; Hara A
Tohoku J Exp Med; 2008 Sep; 216(1):53-9. PubMed ID: 18719338
[TBL] [Abstract][Full Text] [Related]
8. Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers.
Brzozowski T; Konturek PC; Konturek SJ; Sliwowski Z; Pajdo R; Drozdowicz D; Ptak A; Hahn EG
Microsc Res Tech; 2001 Jun; 53(5):343-53. PubMed ID: 11376495
[TBL] [Abstract][Full Text] [Related]
9. [Pharma-Clinics. The drug of the month. Meloxicam (Mobic)].
Scheen AJ
Rev Med Liege; 1997 Apr; 52(4):309-11. PubMed ID: 9273628
[No Abstract] [Full Text] [Related]
10. [Meloxicam].
Sternon J; Appelboom T
Rev Med Brux; 1998 Feb; 19(1):29-32. PubMed ID: 9553452
[TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase-2 enzyme inhibitors: place in therapy.
Noble SL; King DS; Olutade JI
Am Fam Physician; 2000 Jun; 61(12):3669-76. PubMed ID: 10892637
[TBL] [Abstract][Full Text] [Related]
12. Relative safety of meloxicam in NSAID-intolerant patients.
Kosnik M; Music E; Matjaz F; Suskovic S
Allergy; 1998 Dec; 53(12):1231-3. PubMed ID: 9930610
[No Abstract] [Full Text] [Related]
13. Effect of meloxicam on postoperative pain after abdominal hysterectomy.
Thompson JP; Sharpe P; Kiani S; Owen-Smith O
Br J Anaesth; 2000 Feb; 84(2):151-4. PubMed ID: 10743445
[TBL] [Abstract][Full Text] [Related]
14. Meloxicam.
Fleischmann R; Iqbal I; Slobodin G
Expert Opin Pharmacother; 2002 Oct; 3(10):1501-12. PubMed ID: 12387696
[TBL] [Abstract][Full Text] [Related]
15. Valdecoxib for the management of chronic and acute pain.
Joshi GP
Expert Rev Neurother; 2005 Jan; 5(1):11-24. PubMed ID: 15853470
[TBL] [Abstract][Full Text] [Related]
16. Meloxicam in acute UV dermatitis--a pilot study.
Bayerl C; Pagung R; Jung EG
Photodermatol Photoimmunol Photomed; 1998; 14(5-6):167-9. PubMed ID: 9826888
[TBL] [Abstract][Full Text] [Related]
17. [The selective cox-2 inhibitor meloxicam and salicylate therapy].
Tóth K
Ideggyogy Sz; 2005 May; 58(5-6):173-4. PubMed ID: 16021964
[TBL] [Abstract][Full Text] [Related]
18. Anti-inflammatory effect and low ulcerogenic activity of etodolac, a cyclooxygenase-2 selective non-steroidal anti-inflammatory drug, on adjuvant-induced arthritis in rats.
Tachibana M; Inoue N; Yoshida E; Matsui M; Ukai Y; Yano J
Pharmacology; 2003 Jun; 68(2):96-104. PubMed ID: 12711837
[TBL] [Abstract][Full Text] [Related]
19. Platelet function is inhibited by non-selective non-steroidal anti-inflammatory drugs but not by cyclo-oxygenase-2-selective inhibitors in patients with rheumatoid arthritis.
Knijff-Dutmer EA; Kalsbeek-Batenburg EM; Koerts J; van de Laar MA
Rheumatology (Oxford); 2002 Apr; 41(4):458-61. PubMed ID: 11961179
[TBL] [Abstract][Full Text] [Related]
20. The role of cyclooxygenase selective inhibitors in the gastrointestinal tract.
Cryer B
Curr Gastroenterol Rep; 2003 Dec; 5(6):453-8. PubMed ID: 14602052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
